Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TITAN BIO-TECH LTD.

NSE : NABSE : 524717ISIN CODE : INE150C01011Industry : ChemicalsHouse : Private

BSE1087.9051.8 (+5 %)

PREV CLOSE ( ) 1036.10

OPEN PRICE ( ) 1036.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8706

TODAY'S LOW / HIGH ( )1036.10 1087.90

52 WK LOW / HIGH ( ) 373.651419

NSE

This Company is not listed in NSE

Quarters

Select year

( in Million)

Particulars

Sep 2025

Jun 2025

Mar 2025

Dec 2024

Audited / UnAudited

UnAudited

Net Sales

543.55

464.96

351.69

382.76

Total Expenditure

450.27

377.6

305.99

334.29

PBIDT (Excl OI)

93.28

87.36

45.7

48.47

Other Income

13.24

7.22

13.81

15.9

Operating Profit

106.52

94.59

59.51

64.36

Interest

2.24

1.95

0.79

1.48

Exceptional Items

PBDT

104.28

92.64

58.72

62.88

Depreciation

12.1

11.52

8.43

11.83

Profit Before Tax

92.18

81.12

50.29

51.05

Tax

23.56

19.51

12.63

13.03

Provisions and contingencies

Profit After Tax

68.62

61.61

37.66

38.02

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

68.62

61.61

37.66

38.02

Minority Interest

Shares of Associates

9.02

7.02

2.81

5.88

Other related items

Misc. Expenses Written off

Consolidated Net Profit

77.65

68.63

40.47

43.9

Equity Capital

82.64

Face Value (IN RS)

Reserves

Calculated EPS

9.39

8.30

4.89

5.31

Calculated EPS (Annualised)

37.58

33.21

19.58

21.24

No of Public Share Holdings

3654175

3646185

% of Public Share Holdings

44.22

44.12

PBIDTM% (Excl OI)

17.16

18.78

12.99

12.66

PBIDTM%

19.59

20.34

16.92

16.81

PBDTM%

19.18

19.92

16.69

16.42

PBTM%

16.95

17.44

14.29

13.33

PATM%

12.62

13.25

10.70

9.93

Notes

Risk Disclosures on Derivatives

Quarterly Results

TITAN BIO-TECH LTD.